Skip to main content
Premium Trial:

Request an Annual Quote

IntregraGen Wins $2.5M Investment From DSM, Signs Molecular Dx Pact

NEW YORK (GenomeWeb News) — IntegraGen today said it has received a €2 million ($2.5 million) equity investment from DSM Venturing, with which it has also signed a research partnership to develop molecular diagnostics.
 
Under the terms of the agreement, IntegraGen will receive upfront fees, licensing fees, and funding to develop gene-based diagnostic and prognostic tests.
 
DSM, a branch of Royal DSM, will pay royalties earned from product commercialization, although each company will hold rights to developments falling within its area of focus.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.